Remove Ablation Remove Defibrillator Remove Sudden Cardiac Death
article thumbnail

Efficacy of Catheter Ablation for Ventricular Tachycardia in Ischemic Cardiomyopathy Patients without an ICD Implantation

HeartRhythm

Implantable cardioverter defibrillator (ICD) prevents sudden cardiac death (SCD) in patients with ischemic cardiomyopathy (ICM). Catheter ablation has been shown to effectively reduce ventricular tachycardia (VT) recurrence, yet its efficacy in patients without an ICD implantation remains uncertain.

article thumbnail

Ablation of Ventricular Tachycardia in Patients with ischemic cardiomyopathy and without an ICD – For the times they are a-changin´?

HeartRhythm

Recent advancements in catheter ablation for structural ventricular tachycardia (VT), such as high-density mapping and cardiac imaging-based detection of target areas, have significantly improved the efficacy of ablation procedures.

article thumbnail

Stereotactic Body Radiotherapy for Refractory Ventricular Tachycardia Still paving the road to randomized trials.

HeartRhythm

Sudden cardiac death remains the main killer of adults in industrialized countries and reentrant ventricular arrhythmia (VA) is its main underlying mechanism1.

article thumbnail

Management of arrhythmogenic right ventricular cardiomyopathy

Heart BMJ

Arrhythmogenic right ventricular cardiomyopathy (ARVC) is a disease characterised by fibrofatty replacement of the ventricular myocardium due to specific mutations, leading to ventricular arrhythmias and sudden cardiac death. Emerging evidence suggests that combining flecainide and bisoprolol may be efficacious.